Pathology International

4.5k papers and 67.4k indexed citations i.

About

The 4.5k papers published in Pathology International in the last decades have received a total of 67.4k indexed citations. Papers published in Pathology International usually cover Surgery (1.2k papers), Pulmonary and Respiratory Medicine (1.2k papers) and Oncology (1.2k papers) specifically the topics of Sarcoma Diagnosis and Treatment (398 papers), Lymphoma Diagnosis and Treatment (257 papers) and Neuroendocrine Tumor Research Advances (222 papers). The most active scholars publishing in Pathology International are Takaaki Sano, Yutaka Tsutsumi, Koichi Ohshima, Hironobu Sasano and Shigeo Nakamura.

In The Last Decade

Fields of papers published in Pathology International

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Pathology International. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Pathology International

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Pathology International. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Pathology International with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025